(Q45151753)

10 December 2017

title

Interferon-beta stabilizes barrier characteristics of the blood-brain barrier in four different species in vitro (English)

1 reference

10 December 2017

1 reference

9

1 reference

10 December 2017

J Kraus

1

1 reference

10 December 2017

K Voigt

2

1 reference

10 December 2017

A M Schuller

3

1 reference

10 December 2017

M Scholz

4

1 reference

10 December 2017

K S Kim

5

1 reference

10 December 2017

M Schilling

6

1 reference

10 December 2017

W R Schäbitz

7

1 reference

10 December 2017

P Oschmann

8

1 reference

10 December 2017

publication date

27 May 2008

1 reference

Multiple Sclerosis Journal

10 December 2017

published in

1 reference

10 December 2017

volume

14

1 reference

10 December 2017

issue

6

1 reference

10 December 2017

page(s)

843-852

1 reference

Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy.

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088940

Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088940

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088940

Defining the clinical course of multiple sclerosis: Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088940

Mechanisms of action for treatments in multiple sclerosis: Does a heterogeneous disease demand a multi-targeted therapeutic approach?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088940

Mechanisms of action of interferon-beta in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088940

Differential mechanisms of action of interferon-beta and glatiramer aetate in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088940

Insulin-like growth factor I treatment reduces clinical deficits and lesion severity in acute demyelinating experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088940

Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088940

Induction of sTNF-R1 and sTNF-R2 by interferon beta-1b in correlation with clinical and MRI activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088940

Glucocorticoid and type 1 interferon interactions at the blood-brain barrier: relevance for drug therapies for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088940

Interferon-beta stabilizes barrier characteristics of brain endothelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088940

Bovine brain endothelial cells express tight junctions and monoamine oxidase activity in long-term culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088940

In vitro model for evaluating drug transport across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088940

Effects of tumor necrosis factor on receptor-mediated endocytosis and barrier functions of bovine brain capillary endothelial cell monolayers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088940

Degradation of microvascular brain endothelial cell beta-catenin after co-culture with activated neutrophils from patients undergoing cardiac surgery with prolonged cardiopulmonary bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088940

Selective expression of adhesion molecules on human brain microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088940

Molecular sieving characteristics of the cultured endothelial monolayer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088940

The mast cells of the multiple sclerosis brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088940

Effects of barbiturates on hypoxic cultures of brain derived microvascular endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088940

ICAM 1 expression and fluid phase endocytosis of cultured brain microvascular endothelial cells following exposure to interferon beta-1a and TNFalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088940

Human interferons alpha, beta and omega

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088940

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088940

Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088940

Interferon-beta 1b leads to a short-term increase of soluble but long-term stabilisation of cell surface bound adhesion molecules in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088940

Interferon-beta directly influences monocyte infiltration into the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088940

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088940

21 January 2018

Identifiers

DOI

10.1177/1352458508088940

1 reference

10 December 2017

1 reference